Dexamethasone intravitreal implant as an adjuvant treatment for pediatric patients with Coats’ disease

Related authors

• Ana Maria Dorado
• Almudena De-Pablo-Cabrera
• Alicia Muñoz-Gallego
• Luis Moreno-García
• Ana Barceló-Mendiguchía
• Tejada-Palacios Pilar

Related articles

• Scleral communication between Glaucoma drainage device capsule and the suprachoroidal space simulating amelanotic choroidal melanoma
• Viscotrabeculotomy with anterior chamber irrigation versus Ahmed glaucoma valve implantation for silicone oil glaucoma in the pseudophakic eye
• Morphofunctional evaluation of peripapillary retinoschisis associated with myopic posterior staphyloma and hyaloid traction: does it cause peripapillary vitreoretinal traction?
• Multimodal imaging in a patient with combined hamartoma of the retina and retina pigment epithelium
• Retinal vein and artery occlusion as the first manifestation of primary antiphospholipid syndrome in a pediatric patient
• Simultaneous unilateral central retinal vein occlusion and branch retinal artery occlusion after Coronavirus Disease 2019 (COVID-19) mRNA vaccine
• Effects of the epiretinal membrane on the outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion
• Purtscher-like retinopathy in a patient with COVID-19-associated coagulopathy
• Ocular manifestation of vertical transmission of dengue: case report
• Bilateral frosted branch angiitis in an initial case of systemic lupus erythematosus

Click here to search